Dr. Van Spall completed her medical and postgraduate clinical training at the University of Toronto, and earned a Master of Public Health degree at Harvard University. She is an Associate Professor of Medicine, cardiologist, and Director of Digital Health at McMaster University. She serves as Director of Implementation Science at Baim Institute for Clinical Research in Boston. Dr. Van Spall is a clinical trialist and data scientist funded by the Canadian Institutes of Health Research (CIHR), and the Heart and Stroke Foundation of Canada. She has garnered more than $6.2 million in research funding, and has won several research awards, including the prestigious Canadian Institutes of Health Research Mid-Career Lectureship Award in Cardiovascular Sciences and the American Heart Association Nanette Wenger Research Award. Her work is published in high-impact medical journals. She is a member of international guideline committees and clinical trial steering committees. She is an invited speaker, media correspondent, and an editorial board member at several leading CV journals including those in the EHJ, Circulation, and JACC family.
General Statement of Disclosure:
SPEAKER'S BUREAU: Boehringer Ingelheim Pharmaceuticals, Inc(MODEST) OTHER FINANCIAL BENEFIT: Novartis Corporation(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT)